Fundraising Fox
Unephra
Techstars '25San Jose, US · Founded 2023 · 4 employees on LinkedIn · 1 known investors
Find your way into Unephra
Sign up to see every warm intro you have to Unephra
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Unephra team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Unephra develops physiology-based personalized health monitoring technology using sensor hardware and artificial intelligence to enable continuous health tracking and insights. The company serves patients and healthcare providers seeking advanced monitoring solutions in the digital health and medical device space.
Founders & leadership
Unephra was founded in 2023 by Farhad.
Board
Investors · 1
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Company profile
researched Sep 2026Unephra develops a passive, at-home urine-monitoring system marketed as a "Lab-in-Bathroom" for cardiovascular disease management. The device is designed to be non-invasive and non-intrusive, supporting multiple users with authentication, and turns routine bathroom visits into clinical data that is shared between patients and their care teams. The stated focus is heart failure and hypertensive patients, with the goal of preventing avoidable hospitalizations and reducing patient risk through proactive, tailored interventions.
The product combines an adaptive micro-sensor array for urine biomarker measurement with machine learning and statistical analysis, and a cardio-renal physiological model used for personalized risk assessment. Outputs include continuous monitoring of health and disease risks plus actionable insights delivered to clinicians and patients through a dashboard. Company materials note that Unephra is a Non-Significant Risk (NSR) investigational device and is not yet cleared by the FDA.
The company was founded in 2023, is based in San Jose, California, and is described on startup job boards as a pre-seed company with 1-10 employees working across artificial intelligence, health care and health diagnostics.
Business model
Unephra supplies a monitoring device together with a clinician- and patient-facing dashboard, positioning healthcare providers and care teams as the recipients of its real-time clinical insights; the company states its approach improves outcomes while reducing the cost of care. Specific pricing or contracting terms are not stated.
Traction
The website lists Permanente Medicine, the Snyder Lab at Stanford and KeborMed as customers and partners, and carries an endorsement from cardiologist Dr. Milind Dhond of North Bay Health describing at-home monitoring of sodium levels and volume status for heart failure and hypertension patients. The company reports a beta soft launch with early access to device requests and its dashboard ahead of a clinical pilot.
Latest developments
Unephra is in a beta soft launch ahead of a planned clinical pilot, providing early access to device requests and its dashboard.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Unephra is an early-stage, pre-seed company operating at the intersection of AI, health care and health diagnostics, with an investigational (non-FDA-cleared) device in pre-pilot beta.
Technology
The system pairs smart bio-chemical sensing via an adaptive micro-sensor array for urine biomarker measurement with advanced machine learning and statistical analysis, and applies a cardio-renal physiological model to generate personalized risk assessment. Monitoring is passive and occurs during normal bathroom use, with multi-user authentication supported. Clinically, the device is described as measuring parameters such as sodium levels and volume status.
Go-to-market
The company is in a beta soft launch ahead of a clinical pilot, offering early access to device requests and its dashboard and inviting prospects to schedule a demo through its website. It lists clinical and research organizations among its customers and partners, including Permanente Medicine, the Snyder Lab at Stanford, and KeborMed, and publishes clinician testimony from a cardiologist at North Bay Health.
Heart failure and hypertensive patients managed at home, and the cardiologists, care teams and healthcare providers responsible for their remote monitoring and treatment.
Geography
Headquartered in San Jose, California, United States.
History
Founded in 2023 and based in San Jose, California, the company remained at pre-seed stage with 1-10 employees while advancing its passive urine-monitoring device toward a clinical pilot.
Risks & controversies
Unephra states that its product is a Non-Significant Risk (NSR) investigational device that has not been cleared by the FDA, so commercial availability depends on further clinical and regulatory progress.
Compiled by commissioned research from 6 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 1
launches, deals, and filingsUnephra opened early access to its device request process and clinical dashboard as part of a beta soft launch preceding a planned clinical pilot of its passive urine-monitoring device.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 6
primary sources listed
- Unephraunephra.com · web
6 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Unephra do?
- Unephra builds passive at-home urine-monitoring hardware and AI analytics for heart failure and hypertension care.
- Who founded Unephra?
- Unephra was founded by Farhad in 2023.
- Who are Unephra's investors?
- Unephra's investors include Techstars.
- Where is Unephra headquartered?
- Unephra is headquartered in San Jose, US.